Testing for M. gen is recommended for all patients with recurrent urethritis, cervicitis and PID.1 Both women and men with M. gen infections are often asymptomatic and when left untreated, this infection can result in serious health consequences.1,2 Often misdiagnosed, M. gen presents similar symptoms with other urogenital tract bacterial infections, such as Trichomoniasis, Chlamydia or Gonorrhea.3,4 However, treatment for these infections is organism-specific. Accurate diagnosis is critical to ensuring infections are treated successfully. The CDR Labs M. gen assay can be performed on both swab and first catch urine specimens as well as male urethral collections.
- Workowski, et al. Sexually Transmitted Infections Treatment Guidelines 2021. MMWR RecommRep 2021;70
- Jensen et al., Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 2005;81:458–462.
- Martin D. Mycoplasma genitalium infection in men and women. UpToDate. Last updated October 31, 2019. Accessed August 20, 2020. https://www.uptodate.com/contents/mycoplasma-genitalium-infection-in-men-and-women.
- Kent HL. Epidemiology of vaginitis.
- Frølund M, et al. Urethretis-associated pathogens in urine from men with non-gonococcal urethritis: a case-control study. Acta Derm Venereol. 2016;96(5):689-694.
- Le Roy C, et al. French prospective clinical evaluation of the Aptima Mycoplasma genitalium CE-IVD assay and macrolide resistance detection using three distinct assays. J Clin Microbiol. 2017;55(11):3194-3200.
- Aptima Mycoplasma genitalium assay. US package insert AW-17946. Hologic, Inc., 2019.